Performance of ITCI Intracellular Th | 11.2% in 12m
Compare ITCI with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Intracellular Th with its related Sector/Index XLV
Performance Duell ITCI vs XLV
| TimeFrame | ITCI | XLV |
|---|---|---|
| 1 Day | -3.29% | -0.07% |
| 1 Week | -2.48% | 0.40% |
| 1 Month | 5.50% | -2.57% |
| 3 Months | 4.59% | -0.71% |
| 6 Months | 34.3% | 11.70% |
| 12 Months | 11.2% | 6.84% |
| YTD | -0.21% | 1.59% |
| Rel. Perf. 1m | 0.87 | |
| Rel. Perf. 3m | 0.39 | |
| Rel. Perf. 6m | 2.55 | |
| Rel. Perf. 12m | 0.58 |
Is Intracellular Th a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Intracellular Th (NASDAQ:ITCI) is currently (May 2024)
not a good stock to buy. It has a ValueRay Fundamental Rating of -46.97 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ITCI as of May 2024 is 78.31. This means that ITCI is currently undervalued and has a potential upside of +11.33% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ITCI as of May 2024 is 78.31. This means that ITCI is currently undervalued and has a potential upside of +11.33% (Margin of Safety).
Is ITCI a buy, sell or hold?
- Strong Buy: 9
- Buy: 6
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: ITCI is performing better - Values below 0%: ITCI is underperforming
Compare ITCI with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.79% | 8.16% | 16.21% | -13.52% |
| US NASDAQ 100 | QQQ | -3.06% | 8.72% | 16.38% | -23.37% |
| US Dow Jones Industrial 30 | DIA | -2.82% | 7.85% | 20.28% | -4.47% |
| German DAX 40 | DBXD | -2.29% | 7.78% | 16.44% | -1.95% |
| UK FTSE 100 | ISFU | -3.76% | 2.78% | 19.74% | 1.64% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.41% | 2.15% | 29.66% | 21.14% |
| Hongkong Hang Seng | HSI | -9.35% | -0.70% | 33.79% | 25.66% |
| Japan Nikkei 225 | EXX7 | -4.84% | 10.86% | 20.42% | -8.61% |
| India NIFTY 50 | INDA | -3.80% | 2.77% | 13.41% | -18.09% |
| Brasil Bovespa | EWZ | -5.63% | 6.22% | 29.96% | -12.19% |
ITCI Intracellular Th vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.29% | 8.90% | 14.39% | -25.10% |
| Consumer Discretionary | XLY | -3.85% | 7.23% | 22.00% | -10.33% |
| Consumer Staples | XLP | -2.35% | 5.12% | 22.47% | 10.45% |
| Energy | XLE | 1.73% | 9.52% | 26.70% | -7.75% |
| Financial | XLF | -1.45% | 8.40% | 11.88% | -16.19% |
| Health Care | XLV | -2.88% | 8.07% | 22.59% | 4.35% |
| Industrial | XLI | -2.04% | 7.50% | 12.19% | -13.41% |
| Materials | XLB | -2.10% | 9.51% | 18.82% | -2.26% |
| Real Estate | XLRE | -3.30% | 9.87% | 25.33% | 7.71% |
| Technology | XLK | -2.21% | 10.23% | 17.93% | -21.69% |
| Utilities | XLU | -3.90% | 1.66% | 21.97% | 8.34% |
| Aerospace & Defense | XAR | -5.31% | 4.48% | 18.54% | -9.89% |
| Biotech | XBI | -9.92% | 8.08% | 4.85% | 0.37% |
| Homebuilder | XHB | -3.51% | 9.51% | -3.47% | -37.31% |
| Retail | XRT | -2.87% | 10.43% | 13.34% | -9.82% |
Does Intracellular Th outperform its market, is ITCI a Sector Leader?
Yes, over the last 12 months Intracellular Th (ITCI) made 11.19%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.84%.
Over the last 3 months ITCI made 4.59%, while XLV made -0.71%.
Yes, over the last 12 months Intracellular Th (ITCI) made 11.19%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.84%.
Over the last 3 months ITCI made 4.59%, while XLV made -0.71%.
| Period | ITCI | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 5.50% | -2.57% | -2.66% |
| 3 Months | 4.59% | -0.71% | 2.48% |
| 12 Months | 11.19% | 6.84% | 24.71% |